市場調查報告書
商品編碼
1309836
基因合成市場 - 按方法(固相合成)、按服務(抗體 DNA 合成)、按應用(疫苗開發)、按終端用途(學術研究機構、生物製藥公司)分類,以及 2023 - 2032 年預測Gene Synthesis Market - By Method (Solid-phase Synthesis), By Services (Antibody DNA Synthesis), By Application (Vaccine Development) By End-use (Academic and Research Institutes, Biopharmaceutical Companies,) & Forecast 2023 - 2032 |
2023-2032 年,全球基因合成市場規模將呈現可喜的成長。
藥物發現、基因工程和合成生物學等各種研究應用對合成基因的需求不斷成長,推動了市場的成長。客製化設計和合成具有所需序列和功能的基因的能力徹底改變了分子生物學研究。基因合成技術的進步,如高通量合成平台和改進的DNA 測序方法,提高了基因合成的效率和準確性,使基因合成更容易獲得,更具成本效益。
此外,醫療保健和生物技術行業擴大採用基因治療和基因工程方法,也推動了對基因合成服務的需求。此外,學術機構、製藥公司和契約研究組織之間的合作也促進了合成基因的開發和商業化,進一步推動了市場的成長。
整個基因合成市場佔有率根據方法、服務、應用、終端用途和地區進行分類。
在方法方面,到2032 年,基於PCR 的酶合成行業將迎來可觀的成長。 PCR(聚合酶鏈反應)是分子生物學研究中一種用途廣泛的技術,因此成為酶合成的首選方法。 PCR 可以快速、特異地擴增目標基因,從而高效地生產出具有所需特性的酶。此外,PCR 技術的進步,如高保真聚合酶和最佳化的反應條件,提高了酶合成的準確性和效率,進一步推動了酶合成的需求。
就服務而言,到2032 年,病毒DNA 合成的市場佔有率將錄得可觀的估值。病毒DNA 合成對疫苗開發、基因治療和病毒載體生產等各種應用至關重要。基因合成技術的進步使設計和生成客製化的病毒DNA 構建體變得更加容易和更具成本效益。此外,基因遞送系統對病毒載體的需求不斷增加,以及人們對基於病毒的研究的興趣日益濃厚,都促使對病毒DNA 合成服務的需求不斷上升。
根據應用領域,到2032 年,疫苗開發領域的基因合成市場價值將顯著擴大。基因合成可快速、精確地生成編碼疫苗抗原的病毒或細菌基因。這樣就能生產出模擬目標病原體的重組蛋白質或核酸,有助於疫苗的配製。此外,基因合成還有助於新型候選疫苗的開發和現有疫苗的最佳化,從而推動疫苗研究的發展並應對新出現的傳染病。
從2023 年到2032 年,歐洲基因合成行業將呈現可觀的複合年成長率。分子生物學、遺傳學和合成生物學等領域日益增多的研發活動推動了對基因合成服務的需求。其次,政府重點支持生物技術和生命科學領域的計劃,以及學術機構和行業參與者之間的合作,將推動業務成長。此外,基因合成技術的進步和對個性化醫療的日益關注也進一步推動了歐洲基因合成市場的擴張。
Global Gene Synthesis Market size will exhibit commendable growth over 2023-2032.
The growing demand for synthetic genes in various research applications, such as drug discovery, genetic engineering, and synthetic biology, is fueling market growth. The ability to custom-design and synthesize genes with desired sequences and functionalities has revolutionized molecular biology research. Advancements in gene synthesis technologies, such as high-throughput synthesis platforms and improved DNA sequencing methods, have increased the efficiency and accuracy of gene synthesis, making it more accessible and cost-effective.
Additionally, the increasing adoption of gene therapy and genetic engineering approaches in healthcare and biotechnology industries is driving the demand for gene synthesis services. Furthermore, collaborations between academic institutions, pharmaceutical companies, and contract research organizations are facilitating the development and commercialization of synthetic genes, further propelling market growth.
The overall gene synthesis market share is segregated based on methods, services, application, end-use, and region.
With regard to method, the PCR based enzyme synthesis industry will witness considerable growth through 2032. PCR (polymerase chain reaction) is a versatile and widely used technique in molecular biology research, making it a preferred method for enzyme synthesis. PCR allows for rapid and specific amplification of target genes, enabling efficient production of enzymes with desired characteristics. Additionally, advancements in PCR technology, such as high-fidelity polymerases and optimized reaction conditions, have improved the accuracy and efficiency of enzyme synthesis, further driving its demand.
In terms of services, the viral DNA synthesis market share will record a decent valuation by 2032. Viral DNA synthesis is crucial for various applications, including vaccine development, gene therapy, and viral vector production. Advances in gene synthesis technologies have made it easier and more cost-effective to design and generate custom viral DNA constructs. Further, the increasing need for viral vectors in gene delivery systems and the growing interest in viral-based research have contributed to the rising demand for viral DNA synthesis services.
Based on application, the gene synthesis market value from the vaccine development segment will register notable expansion through 2032. Gene synthesis enables the rapid and precise generation of viral or bacterial genes that encode vaccine antigens. This allows for the production of recombinant proteins or nucleic acids that mimic the target pathogen, aiding in vaccine formulation. This apart, gene synthesis facilitates the development of novel vaccine candidates and the optimization of existing ones, contributing to the advancement of vaccine research and the response to emerging infectious diseases.
Europe gene synthesis industry will exhibit a decent CAGR from 2023 to 2032. Increasing research and development activities in fields like molecular biology, genetics, and synthetic biology are driving the demand for gene synthesis services. Secondly, government initiatives focused on supporting biotechnology and life sciences sectors, in line with collaborations between academic institutions and industry players, will fuel business growth. Additionally, advancements in gene synthesis technologies and a rising focus on personalized medicine are further propelling the expansion of the gene synthesis market in Europe.